BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3936919)

  • 1. Pharmacokinetic approaches to drug distribution in the cerebrospinal fluid based on ventricular administration in beagle dogs.
    Levin VA; Landahl HD
    J Pharmacokinet Biopharm; 1985 Aug; 13(4):387-403. PubMed ID: 3936919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CNS toxicity and CSF pharmacokinetics of intraventricular DFMO and MGBG in beagle dogs.
    Levin VA; Byrd D; Campbell J; Davis RL; Borcich JK
    Cancer Chemother Pharmacol; 1984; 13(3):200-5. PubMed ID: 6435895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricular 3-[(4-amino-2-methyl-5-pyrimidinyl)ethyl]-1-(2-chloroethyl)-1-nitro soureas and other nitrosoureas in beagles.
    Levin VA; Byrd D; Campbell J; Giannini DD; Borcich JK; Davis RL
    Cancer Res; 1985 Aug; 45(8):3803-9. PubMed ID: 3860287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain, CSF, and tumor pharmacokinetics of alpha-difluoromethylornithine in rats and dogs.
    Levin VA; Csejtey J; Byrd DJ
    Cancer Chemother Pharmacol; 1983; 10(3):196-9. PubMed ID: 6407769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of an intracerebroventricularly administered antibody in rats.
    Noguchi Y; Kato M; Ozeki K; Ishigai M
    MAbs; 2017 Oct; 9(7):1210-1215. PubMed ID: 28682148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bulk flow in the cerebrospinal fluid system of the dog.
    Sato O; Bering EA; Yagi M; Tsugane R; Hara M; Amano Y; Asai T
    Acta Neurol Scand; 1975 Jan; 51(1):1-11. PubMed ID: 1119314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimetidine elimination from the cerebrospinal fluid of the rat.
    Whittico MT; Giacomini KM
    Pharm Res; 1988 Oct; 5(10):628-33. PubMed ID: 3244614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of distribution of 3H-inulin between the cerebrospinal fluid compartments.
    Vladić A; Klarica M; Bulat M
    Brain Res; 2009 Jan; 1248():127-35. PubMed ID: 19007752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis.
    Fleischhack G; Jaehde U; Bode U
    Clin Pharmacokinet; 2005; 44(1):1-31. PubMed ID: 15634030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid uptake and peripheral distribution of centrally acting drugs: relation to lipid solubility.
    Ochs HR; Greenblatt DJ; Abernethy DR; Arendt RM; Gerloff J; Eichelkraut W; Hahn N
    J Pharm Pharmacol; 1985 Jun; 37(6):428-31. PubMed ID: 2862269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricularly administered bleomycin in beagles.
    Levin VA; Byrd D; Sikic BI; Etiz BB; Campbell J; Borcich JK; Davis RL
    Cancer Res; 1985 Aug; 45(8):3810-5. PubMed ID: 2410102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution in cerebrospinal fluid, blood, and lymph of epidurally injected morphine and inulin in dogs.
    Durant PA; Yaksh TL
    Anesth Analg; 1986 Jun; 65(6):583-92. PubMed ID: 3706799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intrathecal distribution of ACNU by various modes of its administration analyzed by HPLC and autoradiography].
    Hori T; Hirao J; Okamoto H; Nishiyama M; Tanaka S; Muraoka K; Tabuchi F; Tatsuhara T; Nakajima E
    No To Shinkei; 1991 Sep; 43(9):833-41. PubMed ID: 1742091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chronic sheep preparation for the study of drug pharmacokinetics in spinal and ventricular CSF.
    Payne R; Madsen J; Harvey RC; Inturrisi CE
    J Pharmacol Methods; 1986 Dec; 16(4):277-96. PubMed ID: 3784573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of cerebrospinal fluid flow and penetration into brain following lateral ventricle and cisterna magna injections of the tracer [14C]inulin in rat.
    Proescholdt MG; Hutto B; Brady LS; Herkenham M
    Neuroscience; 2000; 95(2):577-92. PubMed ID: 10658638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of nimustine, methotrexate, and cytosine arabinoside during cerebrospinal fluid perfusion chemotherapy in patients with disseminated brain tumors.
    Morikawa N; Mori T; Kawashima H; Fujiki M; Abe T; Kaku T; Konisi Y; Takeyama M; Hori S
    Eur J Clin Pharmacol; 1998 Jul; 54(5):415-20. PubMed ID: 9754986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alteration of cerebrospinal fluid bulk flow on nicotine cerebrospinal fluid exit transfer kinetics.
    Karol MD; Veng-Pedersen P; Brashear RE; DeAtley RE
    J Pharm Sci; 1988 Jul; 77(7):571-8. PubMed ID: 3171944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for entry of plasma insulin into cerebrospinal fluid through an intermediate compartment in dogs. Quantitative aspects and implications for transport.
    Schwartz MW; Bergman RN; Kahn SE; Taborsky GJ; Fisher LD; Sipols AJ; Woods SC; Steil GM; Porte D
    J Clin Invest; 1991 Oct; 88(4):1272-81. PubMed ID: 1918377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetration into and elimination from the cerebrospinal fluid of diltiazem, a calcium antagonist, in anesthetized rabbits.
    Naito K; Nagao T; Otsuka M; Harigaya S; Nakajima H
    Arzneimittelforschung; 1986; 36(1):25-8. PubMed ID: 3954820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone.
    Zimm S; Collins JM; Curt GA; O'Neill D; Poplack DG
    Cancer Res; 1984 Apr; 44(4):1698-701. PubMed ID: 6704975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.